Recent heart failure trials of neurohormonal modulation (OVERTURE and ENABLE): Approaching the asymptote of efficacy?
- 1 June 2002
- journal article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 8 (3) , 124-127
- https://doi.org/10.1054/jcaf.2002.126486
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Clinical trials update: highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS‐II, BEST, AMIOVIRT, V‐MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myoblast transfer for heart failureEuropean Journal of Heart Failure, 2001
- Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trialThe Lancet, 2000
- Update of REACH‐1 and MERIT‐HF clinical trials in heart failureEuropean Journal of Heart Failure, 1999